Security Name | Asset Type |
Shares or Principal Amount |
Market Value |
Percent of Net Assets |
---|---|---|---|---|
Capital Group Central Cash Fund | Short Term | 193,268,995 | $19,326,899,470.00 | 8.66% |
Microsoft Corp. | Equity | 24,566,899 | $10,161,852,102.00 | 4.55% |
Broadcom, Inc. | Equity | 7,605,398 | $9,890,744,045.00 | 4.43% |
Capital Group Central Corporate Bond Fund | Investment Fund | 799,854,036 | $6,630,789,955.00 | 2.97% |
Meta Platforms, Inc., Class A | Equity | 7,757,181 | $3,802,027,124.00 | 1.7% |
UnitedHealth Group, Inc. | Equity | 7,551,038 | $3,727,192,357.00 | 1.67% |
Philip Morris International, Inc. | Equity | 40,872,199 | $3,676,863,022.00 | 1.65% |
Eli Lilly and Co. | Equity | 4,524,666 | $3,410,150,271.00 | 1.53% |
Alphabet, Inc., Class C | Equity | 22,144,097 | $3,095,301,879.00 | 1.39% |
Home Depot, Inc. | Equity | 8,150,079 | $3,102,001,568.00 | 1.39% |
Taiwan Semiconductor Manufacturing Co., Ltd. (ADR) | Equity | 23,691,787 | $3,048,422,233.00 | 1.37% |
JPMorgan Chase & Co. | Equity | 14,401,718 | $2,679,583,651.00 | 1.2% |
Canadian Natural Resources, Ltd. | Equity | 31,851,146 | $2,223,031,518.00 | 1% |
General Electric Co. | Equity | 13,953,860 | $2,189,221,095.00 | 0.98% |
Vertex Pharmaceuticals, Inc. | Equity | 4,178,090 | $1,757,889,587.00 | 0.79% |